Gujarat-based penny stock under Rs 2: Board Announces 1:10 bonus shares & Rs 297 crore of agro commodity supply orders
The stock is trading at 1.10 times its book value and the stock is up by 115 per cent from its 52-week low of Rs 0.52 per share.
Murae Organisor Ltd, an Ahmedabad-based company, has recommended to its shareholders via postal ballot the issuance of bonus shares in a 1:10 ratio, meaning one new fully paid-up equity share of Re 1 for every ten existing fully paid-up equity shares of Re 1. This bonus issue, which will capitalise Rs 1858.96 lakhs from the company's securities premium account received in cash and/or free reserves available as of March 31, 2025, aims to increase the paid-up share capital from 1,85,89,64,310 equity shares to 2,04,48,60,741 equity shares, each valued at Re 1.
Additionally, the company is making significant inroads in the agri-commodity sector, recently securing supply orders worth up to Rs 297 crore from various domestic institutional clients for commodities like mustard seeds, groundnuts, chickpeas, and other oilseeds and pulses. This move is set to boost the company's market presence and operating efficiency, with the first Rs 57 crore tranche of orders to be executed within 30 days. Looking ahead, Murae Organisor plans to invest Rs 20-25 crore in acquiring agricultural land in Kutch, Gujarat, to cultivate pomegranates and establish a distillery, diversifying its portfolio and aiming for sustainable long-term growth by leveraging government support for agricultural and industrial development.
About the Company
Murae Organisor Ltd, incorporated in 2012, operates within the pharmaceutical industry, focusing on the marketing, trading, and distribution of a diverse range of pharmaceutical formulations. The company markets over 120 products under its brand names, such as HYGNEX+, Erolon, and Calcybar, while outsourcing its manufacturing to third-party facilities. In addition to their branded products, Murae also trades in active pharmaceutical ingredients. Their product portfolio spans various therapeutic categories, including antibiotics, antimalarials, antihistamines, analgesics, dermatology products, neurological drugs, gastrointestinal drugs, and various supplements like calcium and multivitamins. Murae maintains an international presence, exporting to more than 15 countries across North America, CIS, Latin America, Africa, and Southeast Asia, with over 60 international products currently under registration.
DSIJ's ‘Penny Pick’ service provides research-backed penny stock recommendations below Rs. 100. If this interests you, do download the service details here.
According to Quarterly Results, the net sales increased by 59,845 per cent to Rs 515.53 crore and net profit increased by 144 per cent to Rs 2.85 crore in Q4FY25 compared to Q4FY24. In its annual results, the net sales increased by 33,554 per cent to Rs 854.82 crore and net profit increased by 14,940 per cent to Rs 7.52 crore in FY25 compared to FY24
The company has a market cap of Rs 208.20 crore and its 100 per cent stake is owned by public shareholders. The stock is trading at 1.10 times its book value and the stock is up by 115 per cent from its 52-week low of Rs 0.52 per share.
Disclaimer: The article is for informational purposes only and not investment advice.